|
Market Closed -
Nyse
02:30:03 11/02/2026 am IST
|
5-day change
|
1st Jan Change
|
|
243.56 USD
|
-2.16%
|
 |
+5.46%
|
-11.48%
|
|
28/01 | |
FA
| |
16/01 |
Ondas Seeks Acquisitions
|
CI
| |
12/01 |
West Pharmaceutical Services, Inc. Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose 3.5mL On-Body Delivery System to AbbVie
|
CI
| |
12/01 |
AbbVie Inc. (NYSE : ABBV) entered into a definitive agreement to acquire Device manufacturing facility in Tempe, Arizona from West Pharmaceutical Services, Inc. (NYSE : WST).
|
CI
| |
12/01 |
AbbVie to Buy Arizona Device Manufacturing Facility From West Pharmaceutical
|
MT
| |
12/01 |
AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma
|
DJ
| |
10/12 |
West Pharmaceutical Services, Inc. Declares Regular Quarterly Dividend on Common Stock, Payable on February 4, 2026
|
CI
| |
10/12 |
West Pharmaceutical Services Keeps Quarterly Dividend at $0.22 a Share, Payable Feb. 4 to Shareholders of Record on Jan. 28
|
MT
| |
12/11 | |
FA
| |
27/25/27 |
West Pharmaceutical Services, Inc. Announces the Launch of its West Synchrony Prefillable Syringe System at CPHI Worldwide in Frankfurt, Germany
|
CI
| |
24/25/24 |
West Pharmaceutical Services Set for Growth After Solid Q3, BofA Securities Says
|
MT
| |
23/25/23 |
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday
|
MT
| |
23/25/23 |
Sector Update: Health Care
|
MT
| |
23/25/23 |
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Oil Surge, Trade Tensions
|
MT
| |
23/25/23 |
West Pharmaceutical Services, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
|
CI
| |
23/25/23 |
West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025
|
CI
| |
23/25/23 |
West Pharmaceutical Services, Inc. Revises Earnings Guidance for the Full-Year 2025
|
CI
| |
23/25/23 |
West Pharma boosts annual profit forecast on strong demand for its drug components
|
RE
| |
23/25/23 |
West Pharmaceutical Services Q3 Non-GAAP Earnings, Revenue Rise; Increases 2025 Guidance
|
MT
| |
23/25/23 |
West Pharmaceutical beats Q3 net sales estimates; lifts FY revenue, EPS outlook
|
RE
| |
23/25/23 |
(WST) West Pharmaceutical Services, Inc. Expects Q4 Revenue Range $790.0M - $800.0M
|
MT
| |
23/25/23 |
(WST) West Pharmaceutical Services, Inc. Expects Q4 Adjusted EPS Range $1.81 - $1.86
|
MT
| |
23/25/23 |
Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q3 Revenue $804.6M, vs. FactSet Est of $785.7M
|
MT
| |
23/25/23 |
Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q3 Adjusted EPS $1.96 per Share, vs. FactSet Est of $1.68
|
MT
| |
25/25/25 |
The Waiting Game
|  |
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
